Copyright
©The Author(s) 2004.
World J Gastroenterol. Jun 15, 2004; 10(12): 1780-1784
Published online Jun 15, 2004. doi: 10.3748/wjg.v10.i12.1780
Published online Jun 15, 2004. doi: 10.3748/wjg.v10.i12.1780
Table 4 Effects of alarelin on GSMC cell cycles (n = 4)
| Group | Concentration of alarelin | G1 phase (%) | S phase (%) |
| Group I | Control | 70.80 ± 11.30 | 17.50 ± 3.40 |
| Group II | 10-9 mol/L alarelin | 80.00 ± 9.42 | 9.93 ± 1.73 |
| Group III | 10-8 mol/L alarelin | 76.60 ± 8.99 | 7.10 ± 1.05 |
| Group IV | 10-7 mol/L alarelin | 79.60 ± 7.43 | 6.60 ± 1.54 |
| Group V | 10-6 mol/L alarelin | 78.50 ± 10.66 | 5.10 ± 1.01 |
| Group VI | 10-5 mol/L alarelin | 80.20 ± 10.03 | 3.20 ± 1.20 |
- Citation: Chen L, He HX, Sun XD, Zhao J, Liu LH, Huang WQ, Zhang RQ. Expression of gonadotropin-releasing hormone receptor and effect of gonadotropin-releasing hormone analogue on proliferation of cultured gastric smooth muscle cells of rats. World J Gastroenterol 2004; 10(12): 1780-1784
- URL: https://www.wjgnet.com/1007-9327/full/v10/i12/1780.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i12.1780